CATALANO, Alfonso
 Distribuzione geografica
Continente #
NA - Nord America 2.557
EU - Europa 1.348
AS - Asia 1.074
SA - Sud America 229
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 33
Totale 5.274
Nazione #
US - Stati Uniti d'America 2.507
SG - Singapore 357
VN - Vietnam 236
UA - Ucraina 231
IT - Italia 203
RU - Federazione Russa 185
BR - Brasile 182
CN - Cina 182
SE - Svezia 159
DE - Germania 136
IE - Irlanda 115
DK - Danimarca 88
HK - Hong Kong 82
FI - Finlandia 71
FR - Francia 69
TR - Turchia 65
KR - Corea 49
GB - Regno Unito 40
CA - Canada 23
BD - Bangladesh 19
MX - Messico 18
BE - Belgio 16
IN - India 16
AR - Argentina 13
ZA - Sudafrica 13
IQ - Iraq 12
EC - Ecuador 11
JP - Giappone 11
ES - Italia 9
PL - Polonia 9
NL - Olanda 7
UZ - Uzbekistan 7
CI - Costa d'Avorio 6
ID - Indonesia 6
VE - Venezuela 6
CL - Cile 5
KE - Kenya 5
PK - Pakistan 5
SA - Arabia Saudita 5
CO - Colombia 4
DZ - Algeria 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
JO - Giordania 3
MY - Malesia 3
PY - Paraguay 3
TH - Thailandia 3
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GY - Guiana 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 5.243
Città #
Chandler 257
Singapore 243
Jacksonville 229
Ashburn 228
Fairfield 166
Des Moines 130
Boardman 118
Dublin 115
San Jose 101
Council Bluffs 99
Hong Kong 77
Ho Chi Minh City 76
Woodbridge 76
Wilmington 74
Ann Arbor 73
New York 72
Dallas 67
The Dalles 60
Hanoi 55
Houston 55
Princeton 47
Lawrence 46
San Mateo 45
Cambridge 43
Beijing 42
Lauterbourg 40
Seattle 40
Hefei 30
Los Angeles 30
Centro 29
Moscow 28
San Diego 22
Munich 19
Helsinki 18
São Paulo 18
Brussels 15
Buffalo 14
Milan 14
Rio de Janeiro 12
Da Nang 11
Haiphong 11
Orem 11
Rome 10
London 9
Santa Clara 9
Tokyo 9
Chicago 8
Frankfurt am Main 8
Warsaw 8
Atlanta 7
Porto 7
Tashkent 7
Turku 7
Wuhan 7
Abidjan 6
Belo Horizonte 6
Brooklyn 6
Miano 6
Mumbai 6
Toronto 6
Boston 5
Mexico City 5
Nairobi 5
Phoenix 5
Shanghai 5
Washington 5
Wuxi 5
Bari 4
Biên Hòa 4
Bắc Ninh 4
Can Tho 4
Cape Town 4
Charlotte 4
Johannesburg 4
Manchester 4
Montreal 4
Pittsburgh 4
Quito 4
Turin 4
Amman 3
Bình Phước 3
Chennai 3
Contagem 3
Curitiba 3
Dhaka 3
Erbil 3
Guangzhou 3
Guarulhos 3
Guayaquil 3
Isidro Casanova 3
Jakarta 3
Jeddah 3
Jiaxing 3
Naples 3
Newark 3
Ninh Bình 3
Norwalk 3
Ottawa 3
Palermo 3
Palo del Colle 3
Totale 3.234
Nome #
Il Celecoxib sensibilizza le cellule tumorali di prostata alla morte cellulare recettore-mediata 173
HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma 168
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. 167
USO FARMACEUTICO DI SEMAFORINE 154
Current perspectives between metabolic syndrome and cancer 152
5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation 151
FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells 150
Adenovirus-mediated wild-type p53 overexpression reverts tumourigenicity of human mesothelioma cells 141
Emerging Role of Stromal Fibroblasts in Epithelial Cancer 139
Angiogenesis and Mesothelioma 134
5-Lipoxigenase regulates malignant mesothelioma cell survival: involvement of vascular endothelial growth factor. 133
The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis. 129
Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo 129
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species 127
Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts 123
Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis 122
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 119
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments 117
Iperespressione della 5-lipossigenasi nel carcinoma renale a cellule chiare. 116
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial. 113
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments (Review). 113
5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 113
Increased expression of 5-lipoxygenase is common in clear cell renal carcinoma 112
Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification 110
The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-κ B to mediate survival and anchorage-independent growth of malignant mesothelioma cells 110
Retinoids induce fibroblast growth factor-2 production in endothelial cells via retinoic acid receptor alpha activation and stimulate angiogenesis in vitro and in vivo 109
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function 108
Semaphorins and their receptors in stem and cancer cells. 106
Lipoxygenase inhibitors for cancer prevention: promises and risks 105
Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma 104
Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells 103
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. 101
Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention 98
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival 98
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma 97
New aspects on the role of lipoxygenases in cancer progression 96
Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis 95
Oxidative Stress and Activation of Survival Pathways as a Basis for Mesothelioma Pathogenesis: New Perspectives for Experimental Therapy 93
Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation 90
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment 88
semaphorins: a further chemotropic family expressed in the thymus 86
The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-KB to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells 84
The effects of insulin and insulin-like growth factors on tumor vascularization: new insights of insulin-like growth factor family in cancer 83
The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-{kappa}B to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells. 78
Neuronal semaphorins regulate a primary immune response 76
Methionine Aminopeptidase-2 regulates human mesothelioma cell survival: role on BCL-2 expression and telomerase activity 61
Totale 5.274
Categoria #
all - tutte 22.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.833


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022350 0 124 0 23 5 21 15 17 23 28 30 64
2022/2023784 59 63 49 70 68 208 2 47 156 7 31 24
2023/2024364 71 10 29 58 59 67 3 4 3 8 7 45
2024/2025672 47 56 28 14 18 26 55 14 185 50 61 118
2025/20261.585 92 93 90 151 172 123 325 153 121 138 57 70
2026/2027148 90 58 0 0 0 0 0 0 0 0 0 0
Totale 5.274